ReviewJournal of experimental & clinical cancer research : CR2019

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma.

Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.